Drug Trial Radar · NCT06502366
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
Last checked: Nov 20, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
424
Actual
Start
Jul 22, 2024
Primary completion
Apr 17, 2026
Study completion Apr 17, 2026
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jul 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the currently approved propellant HFA in participants with asthma.
Conditions
- Asthma
Interventions
BDA MDI HFO 160/180 μgDrug
Budesonide/albuterol pressurized inhalation suspension, HFO
BDA MDI HFA 160/180 μgDrug
Budesonide/albuterol pressurized inhalation suspension, HFA
Placebo MDI HFADrug
Placebo pressurized inhalation suspension, HFA
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in peak FEV1 in 0-60 minutes after dosing at Day 29Time frame: Change from baseline at Day 29
- Change from baseline in peak FEV1 in 0-60 minutes after dosing at Day 29Time frame: Change from baseline at Day 29
Locations
128 sites in 6 countries. Site status is shown where the registry gives one.
Research Site
Mobile, Alabama
Research Site
Sheffield, Alabama
Research Site
Phoenix, Arizona
Research Site
Little Rock, Arkansas
Research Site
Encinitas, California
Research Site
Fullerton, California
Research Site
Gardena, California
Research Site
Huntington Beach, California
Research Site
La Mesa, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Sacramento, California
Research Site
San Bernardino, California
Research Site
San Diego, California
Research Site
San Jose, California
Research Site
Santa Ana, California
Research Site
Stockton, California
Research Site
Westminster, California
Research Site
Englewood, Colorado
Research Site
Wheat Ridge, Colorado
Research Site
Washington D.C., District of Columbia
Research Site
Boynton Beach, Florida
Research Site
Miami, Florida
Research Site
Tallahassee, Florida
Research Site
Tampa, Florida
Research Site
Atlanta, Georgia
Research Site
Rincon, Georgia
Research Site
Savannah, Georgia
Research Site
Meridian, Idaho
Research Site
River Forest, Illinois
Research Site
Evansville, Indiana
Research Site
Valparaiso, Indiana
Research Site
Sioux City, Iowa
Research Site
Louisville, Kentucky
Research Site
Lafayette, Louisiana
Research Site
New Orleans, Louisiana
Research Site
White Marsh, Maryland
Research Site
Flint, Michigan
Research Site
Columbia, Missouri
Research Site
St Louis, Missouri
Showing 40 of 128 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.